Indirect Basal Metabolism Estimation in Tailoring Recombinant Human TSH Administration in Patients Affected by Differentiated Thyroid Cancer: A Hypothesis-Generating Study
Agnese Barnabei(National Cancer Institute), Francesco Torino(University of Rome Tor Vergata), Aurora De Leo(National Cancer Institute), Claudia Annoscia, Rosa Lauretta(Istituti di Ricovero e Cura a Carattere Scientifico), Maddalena Barba(National Cancer Institute), Giovanni Cigliana(National Cancer Institute), Lidia Strigari(Azienda USL di Bologna), Agnese Persichetti(National Cancer Institute), Marialuisa Appetecchia(Istituti di Ricovero e Cura a Carattere Scientifico), Roberto Baldelli(University of Turin), Laura Rizzà(Azienda Ospedaliera San Camillo-Forlanini)
Cited by 4
Related Papers
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index
|European Journal of Endocrinology|2005|317
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer
|Biochimica et Biophysica Acta (BBA) - Molecular Cell Research|2016|151
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer
|Breast Cancer Research and Treatment|2006|140
Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors
|The Oncologist|2014|103